Abstract:AbstractRecent research underscores the significance of the nervous system in tumor progression. Nonetheless, understanding the intricate roles of nerves in gastric tumorigenesis remains limited. Our study aims to elucidate nerve alterations, associated key genes, and signaling pathways during gastric tumorigenesis. We enroll 257 patients with gastric precancerous lesions (GPLs) from four national cohorts. Utilizing immunohistochemistry and digital analysis, we quantified the densities of sympathetic and parasympathetic nerves, as well as Schwann cells in patient slides. We collected three mRNA expression profiles of GPL samples from the gene expression omnibus database and assessed them for nerve expression signatures, differentially expressed genes, enriched pathways, and the immune microenvironment. Parasympathetic nerve and Schwann cell densities display a progressive increase, while sympathetic nerve exhibits an inverse trend along the precancerous spectrums. Notably, CD8+ T cells, natural killer cells, and antigen‐presenting cells (APC) co‐inhibition decrease, while epithelial‐mesenchymal transition increases significantly from early to late premalignancy. Several key nerve‐regulating genes (NTRK3, MYBL2, NRP1, BCL2, CCND1, VEGFA, PLXNA2, ADRB2), and pathways (mitogen‐activated protein kinase [MAPK]/ERK, PI3K/AKT, Wnt) emerge as potential contributors to precancerous progression. Our study reveals a dynamic relationship between sympathetic and parasympathetic nerves, characterized by a gradual increase in parasympathetic nerve and Schwann cell density, contrasting with an inverse trend in sympathetic nerve across precancerous spectrums. Targeting the interaction between tumor cells and nerves, including sympathetic and parasympathetic nerves, has emerged as a promising strategy for the prevention and treatment of gastric cancer.

Vagus Innervation in the Gastrointestinal Tumor: Current Understanding and Challenges.

The nerve cells in gastrointestinal cancers: from molecular mechanisms to clinical intervention

The Vagus Nerve at the Interface of the Microbiota-Gut-Brain Axis

Anti-inflammatory effects of vagal nerve stimulation with a special attention to intestinal barrier dysfunction

Nerves in gastrointestinal cancer: from mechanism to modulations

Enteric neuropathy and the vagus nerve: Therapeutic implications

Emerging Roles of the Nervous System in Gastrointestinal Cancer Development

Vagus Nerve as Modulator of the Brain–Gut Axis in Psychiatric and Inflammatory Disorders

Neuroimmunomodulation of vagus nerve stimulation and the therapeutic implications

Therapeutic Potential of Vagus Nerve Stimulation for Inflammatory Bowel Diseases

Exploring the potential of vagus nerve stimulation in treating brain diseases: a review of immunologic benefits and neuroprotective efficacy

Clinical perspectives on vagus nerve stimulation: present and future

Targeting Tumor Innervation: Premises, Promises, and Challenges

Vascular Cell Adhesion Molecule 1 in the Role of Nerve Tumor Research

The Role of Dynamic Interplay Exists Between Sympathetic and Parasympathetic Nerve in Gastric Tumorigenesis

Gut Microbiota in Brain Tumors: an Emerging Crucial Player.

Atypical Presentation and Postoperative Management of Vagal Nerve Tumors

The Nervous System Contributes to the Tumorigenesis and Progression of Human Digestive Tract Cancer

ID: 220554 Effects of VNS on Rectal Tone and Colon Transit in Rats Mediated Via Vagal-Sacral Pathway

The Gut Microbiome Controls Liver Tumors via the Vagus Nerve

Putative role of non‐invasive vagus nerve stimulation in cancer pathology and immunotherapy: Can this be a hidden treasure, especially for the elderly?